Skip to main content
Caplight Logo









Pyxa Pharmaceuticals

Pyxa Pharmaceuticals

Private
ChinaHealthcare & Life Scienceshttps://pyxapharma.com

Company Overview

Pyxa Pharmaceuticals is a biopharmaceutical company that develops CDK2-selective small molecule inhibitors for the treatment of metastatic breast cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oncologybiopharmaceuticalsmall molecule inhibitorbreast cancer therapyCDK2 inhibitorcancer drugdrug developmenttargeted therapykinase inhibitorpharma biotechclinical trialsprecision medicineNMPAdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pyxa Pharmaceuticals Comparables

Compare Pyxa Pharmaceuticals with similar companies based on industry and business-model similarity.

Pyxa Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Incyclix Bio
84%
Avenzo Therapeutics
80%
Servier
76%

Pyxa Pharmaceuticals Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Pyxa Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Pyxa Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pyxa Pharmaceuticals's valuation, stock price, and market status.

Is Pyxa Pharmaceuticals a public or private company?

Pyxa Pharmaceuticals is a private company.

What is the current stock price of Pyxa Pharmaceuticals?

Pyxa Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Pyxa Pharmaceuticals worth (valuation)?

Valuation information for Pyxa Pharmaceuticals is not publicly available.

Can I buy Pyxa Pharmaceuticals stock?

Pyxa Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pyxa Pharmaceuticals's last funding round?

Funding round information for Pyxa Pharmaceuticals is not publicly available.

Who are the main investors in Pyxa Pharmaceuticals?

Investor information for Pyxa Pharmaceuticals is not publicly disclosed.

Will Pyxa Pharmaceuticals IPO soon?

No public IPO plans have been announced for Pyxa Pharmaceuticals.

How can I track Pyxa Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pyxa Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChina
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?